The rise of Candida auris embodies a serious and growing public health threat: drug-resistant germs.
In the first comprehensive review of access to water, sanitation, and hygiene services (WASH) in healthcare centers, Unicef and the World Health Organization (WHO) found that roughly two billion people use health facilities lacking basic water services globally – while almost 900 million people use health centers with no water services at all.
The risks involved in medical tourism aren't just personal. Having surgery abroad could also mean bringing back a drug-resistant superbug and putting people in the patient’s home country at risk, Canadian officials warn.
Researchers are worried about the fast development and spread of "superbugs," which are bacteria that do not respond to antibiotics. For the first time, scientists have found potent superbugs in the remote High Arctic of Norway, which they fear does not bode well for the future of antibiotic treatments.
This year’s event will gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships, to discuss the growing threat of antibiotic resistance.
The US National Biodefense Strategy, released last year, highlights the need to reduce the emergence and spread of superbugs both domestically and internationally, and accelerate the development of new drugs, diagnostic tests, and vaccines.
Carbapenemase-producing carbapenem-resistant Enterobacteriaceae have the potential for epidemic spread through person-to-person transmission and horizontal transfer of resistance mechanisms.
Researchers found that interferons are fighting back against the bacterial Klebsiella infection.
Researchers have identified structures that make Pseudomonas aeruginosa virulent, opening doors to developing drugs that can fight it.
Thousands of Californians die every year from infections they acquired in hospitals, but their death certificates do not capture that data.